| Health Canada | news releases
Today, the Honourable Patty Hajdu, Minister of Health, announced $20 million in funding for the distribution of naloxone kits and opioid overdose response training to support communities that have been particularly affected by the opioid overdose crisis and are experiencing challenges in improving health outcomes of their residents.
| Health Canada | statements
As part of Health Canada’s continuing commitment to openness and transparency on all information relating to COVID-19 vaccines, the Department is updating Canadians on new actions it has taken.
| Health Canada | media advisories
The Honourable Patty Hajdu, Minister of Health, will announce funding under the Substance Use and Addictions Program (SUAP) to provide opioid overdose response training and improve access and distribution of naloxone.
| Health Canada | statements
Tuberculosis (TB) is a preventable and treatable disease, and yet it remains one of the world’s most common infectious diseases. In Canada, TB disproportionately affects Indigenous peoples and vulnerable populations. Today, on World Tuberculosis Day, we reaffirm Canada’s commitment with other nations in ending the worldwide TB epidemic by 2030, as set out in the United Nations Sustainable Development Goals.
| Health Canada | statements
Health Canada reassures Canadians that the AstraZeneca COVID-19 vaccine continues to be safe and effective at protecting them against COVID-19 and encourages people to get immunized with any of the COVID-19 vaccines that are authorized in Canada.
| Health Canada | statements
Health Canada confirms that the benefits of the AstraZeneca COVID-19 vaccine in protecting Canadians from COVID-19 continue to outweigh the risks, and encourages Canadians to get immunized with any of the COVID-19 vaccines that are authorized in Canada.
| Health Canada | news releases
Today, the Minister of Health, the Honourable Patty Hajdu, the Minister of Digital Government, the Honourable Joyce Murray, and the Minister of Innovation, Science and Industry, the Honourable Francois-Philippe Champagne, welcomed the Council’s Interim report on the Social and Economic Determinants of App Adoption, Retention and Use.
| Health Canada | news releases
Health Canada announces new guidance issued today by the Access Consortium—a coalition of regulatory authorities from Canada, the U.K., Australia, Singapore and Switzerland.
| Health Canada | statements
Today, Health Canada authorized the COVID-19 vaccine manufactured by Janssen Inc. Health Canada received an application from Janssen Inc. for authorization of its COVID-19 vaccine on November 30, 2020. After a thorough, independent review of the evidence, the Department has determined that the vaccine meets Canada’s stringent safety, efficacy and quality requirements.
| Health Canada | media advisories
On March 5, 2021, Health Canada officials will hold a technical briefing on the authorization of the COVID-19 vaccines in Canada.
